Skip to main content
Jorge Monge Urrea, MD, Hematology, Aurora, CO

JorgeMonge UrreaMD

Hematology Aurora, CO

Hematologic Oncology

Assistant Professor of Medicine, University of Colorado Anschutz Medical Campus

Overview of Dr. Monge Urrea

Plasma Cell Disorders,
Autologous Stem Cell Transplantation and Cellular Therapy

  • Office

    Uchealth Hematology Clinic Anschutz Medical Campus 1665 Aurora Court Anschutz Cancer Pavilion
    3rd Floor
    Aurora, CO 80045
    Fax+1 720-848-1786

Education & Training

  • Universidad Anahuac School of Medicine
    Universidad Anahuac School of MedicineClass of 2011

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2024 - 2025
  • CT State Medical License
    CT State Medical License 2024 - 2024
  • NY State Medical License
    NY State Medical License 2017 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Scott Wadler Memorial Fellow Clinical Research Award Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, 2020
  • 5 time recipient of the Academic Excellence Award Universidad Anahuac, 2004-2008
  • Outstanding Performance Award CENEVAL

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition  
    Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Leukemia, 1/1/2014
  • Sudden cardiac arrest at the finish line: in coronary ectopia, the cause of ischemia is from intramural course, not ostial location  
    Joggerst S, Monge J, Uribe C, Sherron S, Angelini P, Tex Heart Inst J, 1/1/2014
  • Staging and prognostication of multiple myeloma  
    Fonseca R, Monge J, Dimopoulos MA, Expert Rev Hematol, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Harnessing the Epichaperome As a Therapeutic Approach in Multiple Myeloma
    Jorge Monge, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Cyclophosphamide, bortezomib, and dexamethasone (CYBORD) treatment for relapsed/refractory multiple myeloma
    Monge J, Kortum KM, Stewart AK, Bergsagel PL, Mikhael J, Reeder CB, Mayo A, Fonseca R, J Clin Oncol, 1/1/2014
  • Calcium Isotopic Composition and Its Association With Multiple Myeloma Disease Activity
    Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Blood, 1/1/2013
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish